Jack A. Sargeant

2.2k total citations
54 papers, 1.0k citations indexed

About

Jack A. Sargeant is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jack A. Sargeant has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 24 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Molecular Biology. Recurrent topics in Jack A. Sargeant's work include Diabetes Treatment and Management (16 papers), Metabolism, Diabetes, and Cancer (10 papers) and Diet and metabolism studies (9 papers). Jack A. Sargeant is often cited by papers focused on Diabetes Treatment and Management (16 papers), Metabolism, Diabetes, and Cancer (10 papers) and Diet and metabolism studies (9 papers). Jack A. Sargeant collaborates with scholars based in United Kingdom, Japan and Saudi Arabia. Jack A. Sargeant's co-authors include Melanie J. Davies, James A. King, Kamlesh Khunti, Thomas Yates, David J. Stensel, Joseph Henson, Guruprasad P. Aithal, Scott A. Willis, David R. Webb and Francesco Zaccardi and has published in prestigious journals such as Diabetes Care, Journal of Nutrition and Medicine & Science in Sports & Exercise.

In The Last Decade

Jack A. Sargeant

47 papers receiving 1.0k citations

Peers

Jack A. Sargeant
Marieke Snel Netherlands
Seng Khee Gan Australia
Zilin Sun China
Jang Won Son South Korea
Stuart A. Ritchie United Kingdom
Jack A. Sargeant
Citations per year, relative to Jack A. Sargeant Jack A. Sargeant (= 1×) peers Fotios Iliadis

Countries citing papers authored by Jack A. Sargeant

Since Specialization
Citations

This map shows the geographic impact of Jack A. Sargeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack A. Sargeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack A. Sargeant more than expected).

Fields of papers citing papers by Jack A. Sargeant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack A. Sargeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack A. Sargeant. The network helps show where Jack A. Sargeant may publish in the future.

Co-authorship network of co-authors of Jack A. Sargeant

This figure shows the co-authorship network connecting the top 25 collaborators of Jack A. Sargeant. A scholar is included among the top collaborators of Jack A. Sargeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack A. Sargeant. Jack A. Sargeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández, Gema, Zuzanna Drebert, Joseph Henson, et al.. (2025). Age at type 2 diabetes diagnosis and risk of cancer: Cohort study in over 1 million individuals from the TriNetX US Collaborative Network. Journal of Diabetes and its Complications. 40(1). 109210–109210.
2.
Barker, Mary M., Jack A. Sargeant, Dimitris Papamargaritis, et al.. (2025). Burden of vascular risk factors by age, sex, ethnicity and deprivation in young adults with and without newly diagnosed type 2 diabetes. Diabetes Research and Clinical Practice. 220. 112002–112002. 2 indexed citations
3.
Savage, Matthew J., et al.. (2025). Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions. Diabetes & Metabolism Journal. 49(5). 934–950.
5.
Barker, Mary M., et al.. (2024). Age at onset of type 2 diabetes and prevalence of vascular disease and heart failure: Systematic review and dose-response meta-analysis. Journal of Diabetes and its Complications. 38(10). 108849–108849. 1 indexed citations
6.
Wilkinson, Thomas J., Dimitris Papamargaritis, James A. King, et al.. (2024). Preservation of healthy lean body mass and function during weight loss. Clinical Obesity. 14(4). e12683–e12683.
8.
Willis, Scott A., Jack A. Sargeant, Christopher R. Bradley, et al.. (2024). Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training. Diabetes Obesity and Metabolism. 26(9). 4030–4042. 4 indexed citations
9.
Belfield, A., Thomas J. Wilkinson, Joseph Henson, et al.. (2024). Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus. Age and Ageing. 53(5). 5 indexed citations
10.
Yates, Thomas, Joseph Henson, Benjamin D. Maylor, et al.. (2023). Moderate-intensity stepping in older adults: insights from treadmill walking and daily living. International Journal of Behavioral Nutrition and Physical Activity. 20(1). 31–31. 7 indexed citations
11.
Willis, Scott A., Siôn Parry, Gaël Ennequin, et al.. (2023). The effect of acute and chronic exercise on hepatic lipid composition. Scandinavian Journal of Medicine and Science in Sports. 33(5). 550–568. 3 indexed citations
12.
Willis, Scott A., Joseph Henson, Jack A. Sargeant, et al.. (2023). Associations of objectively measured physical activity, sedentary time and cardiorespiratory fitness with adipose tissue insulin resistance and ectopic fat. International Journal of Obesity. 47(10). 1000–1007. 5 indexed citations
13.
Barker, Mary M., Melanie J. Davies, Francesco Zaccardi, et al.. (2023). Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion. Diabetes Care. 46(3). 579–586. 20 indexed citations
14.
Papamargaritis, Dimitris, et al.. (2023). Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management. Journal of Obesity & Metabolic Syndrome. 32(1). 25–45. 69 indexed citations
15.
Sargeant, Jack A., Abdullah Almaqhawi, Ehtasham Ahmad, et al.. (2023). The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials. Obesity Reviews. 24(4). e13553–e13553. 13 indexed citations
17.
18.
Barker, Mary M., Francesco Zaccardi, Emer M. Brady, et al.. (2022). Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis. World Journal of Diabetes. 13(3). 260–271. 13 indexed citations
19.
Henson, Joseph, Alex V. Rowlands, Jack A. Sargeant, et al.. (2020). Device‐measured physical activity and its association with physical function in adults with type 2 diabetes mellitus. Diabetic Medicine. 38(6). e14393–e14393. 16 indexed citations
20.
Sargeant, Jack A., Guruprasad P. Aithal, Elizabeth J. Simpson, et al.. (2018). Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease. European Journal of Applied Physiology. 118(4). 817–828. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026